Press Releases
Research progress on the effect of gut and tumor microbiota on antitumor efficacy and adverse effects of chemotherapy drugs
Chemotherapy is one of the most effective methods of systemic cancer treatment. Chemotherapy drugs are delivered through the blood circulation system, and they can act at all stages of the cell cycle, and can target DNA, topoisomerase, or tubulin to prevent the growth...
Effects of microbiota on anticancer drugs: Current knowledge and potential applications
Over the last decade, mounting evidence has revealed the key roles of gut microbiota in modulating the efficacy and toxicity of anticancer drugs, via mechanisms such as immunomodulation and microbial enzymatic degradation. As such, human microbiota presents as an...
New findings reveal how to regulate the microbiota to modify the course of lung cancer
New findings reveal how to regulate the microbiota to modify the course of lung cancer Three studies show the importance of the microbiota in the onset, extension and evolution of the disease. “They open up new avenues for early diagnosis and new treatments by...
Estudio REVERS sobre degeneración macular y edad (DMAE)
Dr. Jordi Monés: "Through the impact on the microbiota it is possible to influence...
European Lung Cancer Week
IGEN: The microbiota or 'second brain', in the scientific spotlight to achieve a better prognosis of lung cancer “As a consequence of the Covid-19 pandemic, there were delays in the diagnosis of lung tumors” Igen Biolab has completed the inclusion of patients in a...
An altered gut microbiota can affect sports performance
Maintaining a healthy and varied bacterial flora helps to achieve post-holiday goals such as following a balanced diet or staying in shape An unstable microbiota can cause more fatigue in the athlete Prebiotic foods, with fermentable fiber and polyphenols, help...
A trial of one of Igen Biolab Group’s products to investigate Age-Related Macular Degeneration (AMD) is approved
Javier Asarta, CEO of the Igen Biolab Group: “AMD affects some 700,000 people in Spain and currently has no treatment”.Dr Jordi Monés, study author: “As well as the medical benefits for patients, it reduces the socio-economic burden by preventing or improving the...
Biotech company Igen Biolab Group to raise up to EUR 15m for its clinical trials on lung cancer
Madrid, April 25, 2019.- Igen Biolab Group, a Spanish-based biotech company focused on the study of the microbiota impact on the prevention and treatment of cancer, and of neurodegenerative and metabolic diseases, has opened a financing round of up to 15 million euros...
New sponsorship for culture by IGEN Biotech
Among his Corporate Social Responsibility strategy, IGEN Biotech has expanded his programs of sponsorship on culture with a new agreement with the Culture Department of the regional Government of Catalonia (Spain), the Council of Barcelona, La Vanguardia,...
